Piramal Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PIRAMAL, and what generic and branded alternatives to PIRAMAL drugs are available?
PIRAMAL has twenty approved drugs.
Drugs and US Patents for Piramal
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Piramal Critical | ROCURONIUM BROMIDE | rocuronium bromide | INJECTABLE;INJECTION | 210437-002 | Aug 13, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Piramal Critical | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 215516-001 | May 24, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Piramal Critical | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 215516-003 | Dec 14, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Piramal | CLOBAZAM | clobazam | TABLET;ORAL | 209808-002 | Oct 22, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Piramal Critical | GLYCOPYRROLATE | glycopyrrolate | INJECTABLE;INJECTION | 210842-001 | Oct 25, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Piramal | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 212190-001 | May 4, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for PIRAMAL drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
Similar Applicant Names
Here is a list of applicants with similar names.